BioRestorative Current Deferred Revenue vs Net Tangible Assets Analysis
BRTX Stock | USD 1.46 0.01 0.68% |
BioRestorative Therapies financial indicator trend analysis is way more than just evaluating BioRestorative Therapies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRestorative Therapies is a good investment. Please check the relationship between BioRestorative Therapies Current Deferred Revenue and its Net Tangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.
Current Deferred Revenue vs Net Tangible Assets
Current Deferred Revenue vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRestorative Therapies Current Deferred Revenue account and Net Tangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between BioRestorative Therapies' Current Deferred Revenue and Net Tangible Assets is -0.48. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of BioRestorative Therapies, assuming nothing else is changed. The correlation between historical values of BioRestorative Therapies' Current Deferred Revenue and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of BioRestorative Therapies are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Current Deferred Revenue i.e., BioRestorative Therapies' Current Deferred Revenue and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | -0.48 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from BioRestorative Therapies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.Selling General Administrative is likely to drop to about 7.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.2 M in 2024
BioRestorative Therapies fundamental ratios Correlations
Click cells to compare fundamentals
BioRestorative Therapies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioRestorative Therapies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.5M | 4.3M | 22.5M | 16.4M | 12.6M | 13.2M | |
Other Current Liab | 4.5M | 609.2K | 15.9K | 5.5M | 2.3M | 1.7M | |
Total Current Liabilities | 13.7M | 1.0M | 363.8K | 440.3K | 2.6M | 2.5M | |
Total Stockholder Equity | (12.8M) | (1.3M) | 21.6M | 15.8M | 10.0M | 10.5M | |
Accounts Payable | 2.0M | 118.9K | 50.8K | 170.9K | 189.4K | 179.9K | |
Other Current Assets | 35.2K | 105.4K | 436.2K | 363.1K | 305.2K | 320.5K | |
Total Liab | 14.2M | 5.7M | 856.5K | 602.6K | 2.6M | 2.5M | |
Intangible Assets | 739.2K | 664.3K | 589.7K | 803.4K | 713.7K | 971.2K | |
Common Stock | 7.8K | 286.2K | 353.0 | 369.0 | 471.0 | 447.45 | |
Property Plant Equipment | 658.3K | 21.9K | 395.8K | 502.8K | 578.2K | 351.7K | |
Short Long Term Debt Total | 7.8M | 4.8M | 670.7K | 301.6K | 162.3K | 154.2K | |
Property Plant And Equipment Net | 658.3K | 495.8K | 395.8K | 502.8K | 507.5K | 420.0K | |
Net Debt | 7.8M | 1.7M | (20.4M) | (1.4M) | (722.1K) | (686.0K) | |
Retained Earnings | (78.6M) | (89.8M) | (134.1M) | (152.6M) | (146.7M) | (139.4M) | |
Cash | 1.7K | 3.1M | 21.0M | 1.7M | 884.4K | 840.2K | |
Non Current Assets Total | 1.4M | 1.2M | 985.5K | 1.3M | 1.2M | 1.3M | |
Long Term Debt | 194.3K | 523.9K | 4.3M | 191.0K | 219.7K | 208.7K | |
Cash And Short Term Investments | 1.7K | 3.1M | 21.0M | 14.7M | 11.1M | 11.6M | |
Common Stock Shares Outstanding | 19.5K | 394.7K | 1.2M | 3.6M | 4.2M | 4.4M | |
Liabilities And Stockholders Equity | 1.5M | 4.3M | 22.5M | 16.4M | 12.6M | 13.2M | |
Non Current Liabilities Total | 521.9K | 4.6M | 492.7K | 162.3K | 186.7K | 177.3K | |
Other Stockholder Equity | 65.8M | 88.2M | 155.7M | 146.6M | 156.7M | 164.5M | |
Total Current Assets | 68.9K | 3.2M | 21.5M | 15.1M | 11.4M | 12.0M | |
Short Term Debt | 7.2M | 316.7K | 297.1K | 278.7K | 162.3K | 154.2K | |
Net Tangible Assets | (13.5M) | (2.0M) | 21.0M | 15.0M | 17.3M | 18.1M | |
Short Long Term Debt | 3.5M | 3.6M | 7.1M | 59.0K | 53.1K | 50.4K | |
Net Receivables | 32K | 17K | 5K | 16K | 19.3K | 22.7K | |
Net Invested Capital | (5.6M) | 2.9M | 21.8M | 15.8M | 10.0M | 5.9M | |
Net Working Capital | (13.7M) | 2.1M | 21.1M | 14.7M | 8.8M | 9.2M | |
Capital Stock | 7.8K | 286.2K | 15.8K | 15.6K | 17.9K | 17.0K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.